Machine Learning (2)

The term “hallucination” has gained prominence as a fascinating yet challenging aspect of generative artificial intelligence (AI). A hallucination in this context refers to a model’s output ...

Life sciences enterprises across the globe are turning to artificial intelligence (AI), recognizing it as one of the most prominent technological investments right now. AI has taken the ...

Right now, life sciences companies have a pressing need: a flexible and high-performance data processing and analysis system that can handle diverse data applications such as SQL analytics, ...

In these unprecedented times, the value of data science is clear, especially in the pharma and life sciences industries. The emergence of data science has brought access to technologies ...

Everywhere we look, data is increasing in volume and complexity. Businesses are looking for new ways to take advantage of this valuable resource and enhance the speed and accuracy of ...

Introduction It takes 10 to 15 years to develop one successful drug, and the price of new drug approvals has risen to roughly $2.6 BN, according to a study by Tufts Center for the Study of ...

Problem Rare diseases, also known as orphan diseases, affect a small percentage of the patient population (<200,000 patients in the US but usually much lower) with much higher drug ...

With the increase in the number of touchpoints for a Healthcare Physician (HCP), it has become more important for pharmaceutical companies to personalize marketing efforts at the HCP level. ...

As of April 20, there are 2,440,528 confirmed coronavirus cases and 167,592 deaths globally. Currently, the U.S. continues as the hardest-hit country in the world, with 749,666 total cases ...